The Laboratory was established in 1941 as a research and production centre, known as Drug Research Laboratory of J&K State and was later taken over by Council of Scientific & Industrial Research (CSIR) of Govt. of India in December 1957 as Regional Research Laboratory, Jammu. In view of its core strength in natural products based drug discovery, the mandate of Institute was redefined in 2005 and its name changed to Indian Institute of Integrative Medicine (IIIM)

Translational Health Science and Technology Institute (THSTI) is an autonomous Institute of the Department of Biotechnology (DBT), Ministry of Science and Technology, Govt. of India. The institute is an integral part of the interdisciplinary NCR Biotech Science Cluster (NCR BSC) located at Faridabad, and is designed with the mission to conduct innovative translational research to translate concepts into products to improve human health.

Project : Evaluation of Rationally Designed Influenza Vaccines (ENDFLU)

Institute of Nano Science and Technology (INST), Mohali (Punjab), an autonomous institution of Department of Science and Technology (DST), Government of India, has been established under the umbrella of NANO MISSION, initiated by DST to boost research and development in the field of Nanoscience and Nanotechnology in India. INST started its activities on 3rd January 2013, the date on which its first Director was appointed. The institute is currently operating from its transit campus at Habitat Centre, Sector-64, Phase-X, Mohali, Punjab.

Institute of Life Sciences(ILS), Bhubaneswar an autonomous Institute of the Department of Biotechnology, Ministry of Science & Technology, Government of India is an emerging multidisciplinary institute engaged in advanced research invites applications from Indian Nationals to join in the following position in INDO-UK collaborative project “The development and implementation of sensors and treatment technologies for freshwater systems in India ".

Post : Project Assistant (01 No)

Koye was launched to seek, identify and introduce to the market, essential drugs in areas of Speciality Primary Care, Respiratory, Gynaecology, IVF, Diabetology, Metabolics that are unmet by the national and the international pharmaceutical companies.

Post : Market Development Manager - 11 Posts

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms.

Pulse is a fast-growing Pharmaceutical company with a vertically & diagonally integrated business model, focused on providing innovative product solutions to a large number of people around the world, to help them manage their health better & lead a quality life.  A leading name in the Pharmaceutical industry with over two decades of expertise in providing pathbreaking solutions, Pulse today, has a pan-India presence with a strong field force of over 500 employees, who reach out to over 40, 000 Health Care Professionals.

India Medtronic Private Limited, a wholly owned subsidiary of Medtronic plc announced the launch of the TYRX™ Absorbable Antibacterial Envelope (TYRX Envelope) - an absorbable, single-use, antibacterial envelope designed to stabilize a cardiac implantable electronic device (CIED) or implanted neurostimulator while releasing antimicrobial agents over a minimum of seven days.

Takeda Pharmaceutical Company Limited announced that the first subject was dosed in its Phase 1/2 immunogenicity and safety study of Novavax’ COVID-19 vaccine candidate (TAK-019) in Japan. Earlier this month, Takeda completed enrollment in the company’s Phase 1/2 immunogenicity and safety study of Moderna’s COVID-19 vaccine candidate (TAK-919) in Japan.

Moderna, Inc a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announces that it has completed manufacturing of clinical trial material for its variant-specific vaccine candidate, mRNA-1273.351, against the SARS-CoV-2 variant known as B.1.351 first identified in the Republic of South Africa, and has shipped doses to the National Institutes of Health (NIH) for a Phase 1 clinical trial that will be led and funded by the NIH’s National Institute of Allergy and Infectious Diseases (NIAID).

The ECHS Central Organisation is located at Delhi and functions under the Chief of Staff Committee (COSC) through AG and DGDC&W in Army HQ. The Central organisation is headed by Managing Director, ECHS, a serving Major General. There are 28 Regional Centres ECHS and 426 ECHS Polyclinics. ECHS is also an attached office of Dept of Ex-Servivemen Welfare (DoESW), Ministry of Defence (MoD) as are Directorate General Resettlement(DGR) and Kendriya Sainik Board (KSB).

National Institute of Pharmaceutical Education & Research, Guwahati (NIPER-G) is an Autonomous Institute of National importance and the first National pharma institute in North-East India set up by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt. of India by an Act of Parliament, to impart high quality Education and Research in the area of Pharmaceutical Sciences.

The Institute intends to fill the following posts on Direct Recruitment/Contract basis:

Institute was founded in 2020 to provide students with excellent academic programs and a nurturing environment with close student-teacher relationships. Institute is a private yet affordable elementary institution offering a stimulating curriculum and a supportive environment to ensure our students experience success every day.

Principal / Professor - 01
Associate Professor - 01
Assistant Professor - 09

Qualification, Experience & Salary as per PCI Norms.

Sri Sai Pharmacy was established in 2019 with a view to impart the best in pharmacy education. Since inception, through its commitment to Excellence and to raise its standard of education, it has acquired a name for itself. The institute is committed to impart the highest quality of education and exposure to help develop the next generation of Pharma and management leaders with global outlook and capability of adapting to changing requirements.

The Geltec Group has been a pioneer in the field of soft gelatin capsules for more than four decades. With state of the art manufacturing facilities in Bengaluru, Karnataka and Sarigam, Gujarat, Geltec holds a strong position in the soft gelatin capsule and gelatin enrobed tablet industry. The total annual manufacturing capacity is over 4 billion capsules which can be supplied in bulk or packaged forms.

Zydus Cadila, a leading Indian Pharmaceutical company is a fully integrated, global healthcare provider. With in-depth domain expertise in the field of healthcare, it has strong capabilities across the spectrum of the pharmaceutical value chain.

Medpace is a full-service clinical contract research organization (CRO). We provide Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Our mission is to accelerate the global development of safe and effective medical therapeutics through its scientific and disciplined approach. We leverage local regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system, anti-viral and anti-infective.

Novick Bio-Sciences is a rapid-growing Contract Research Organization providing Integrated Drug Discovery  & Formulation research and development (Innovative & Generic)  to Global Pharmaceutical, Bio-tech, Agrochemical Research Organizations and Academics to help our customers achieve their goals.

Emcure Pharmaceuticals Ltd. is a fully integrated pharmaceutical company, engaged in develop manufacturing and marketing a broad range of pharmaceutical products globally having presence in more than 70 countries and a workforce of 10,000+ across the globe.

MSTG [Manufacturing Science and Technology Group]